Verity Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.43M | Buy |
53,142
+24
| +0% | +$1.69K | 1.44% | 11 |
|
|
2025
Q4 | $3.57M | Buy |
53,118
+5,506
| +12% | +$370K | 1.53% | 8 |
|
|
2025
Q3 | $3.49M | Buy |
47,612
+3,202
| +7% | +$213K | 1.14% | 18 |
|
|
2025
Q2 | $2.31M | Buy |
44,410
+2,287
| +5% | +$130K | 1.1% | 20 |
|
|
2025
Q1 | $2.69M | Sell |
42,123
-3,493
| -8% | -$203K | 1.09% | 19 |
|
|
2024
Q4 | $2.18M | Buy |
45,616
+7,368
| +19% | +$378K | 1.23% | 13 |
|
|
2024
Q3 | $2.19M | Sell |
38,248
-2,345
| -6% | -$134K | 0.82% | 28 |
|
|
2024
Q2 | $2.13M | Buy |
40,593
+1,504
| +4% | +$66K | 0.83% | 31 |
|
|
2024
Q1 | $1.59M | Buy |
39,089
+10,461
| +37% | +$392K | 0.89% | 25 |
|
|
2023
Q4 | $1.06M | Sell |
28,628
-2,682
| -9% | -$101K | 0.68% | 36 |
|
|
2023
Q3 | $1.2M | Buy |
31,310
+5,741
| +22% | +$235K | 0.88% | 29 |
|
|
2023
Q2 | $922K | Sell |
25,569
-5,784
| -18% | -$197K | 0.68% | 40 |
|
|
2023
Q1 | $1.2M | Buy |
31,353
+4,778
| +18% | +$224K | 0.71% | 41 |
|
|
2022
Q4 | $1.51M | Sell |
26,575
-5,313
| -17% | -$272K | 1.29% | 18 |
|
|
2022
Q3 | $1.26M | Buy |
+31,888
| New | +$1.41M | 1.3% | 15 |
|
|
2022
Q1 | $1.25M | Sell |
31,296
-4,501
| -13% | -$160K | 0.79% | 31 |
|
|
2021
Q4 | $1.44M | Buy |
35,797
+5,556
| +18% | +$207K | 0.85% | 19 |
|
|
2021
Q3 | $1.23M | Buy |
30,241
+8,106
| +37% | +$339K | 0.8% | 22 |
|
|
2021
Q2 | $1M | Buy |
22,135
+2,825
| +15% | +$125K | 0.55% | 40 |
|
|
2021
Q1 | $805K | Buy |
19,310
+735
| +4% | +$33.6K | 0.48% | 53 |
|
|
2020
Q4 | $793K | Sell |
18,575
-1,168
| -6% | -$42K | 0.55% | 41 |
|
|
2020
Q3 | $519K | Sell |
19,743
-2,363
| -11% | -$65.8K | 0.4% | 62 |
|
|
2020
Q2 | $593K | Sell |
22,106
-1,746
| -7% | -$39.4K | 0.55% | 42 |
|
|
2020
Q1 | $429K | Sell |
23,852
-5,885
| -20% | -$112K | 0.54% | 59 |
|
|
2019
Q4 | $527K | Sell |
29,737
-1,134
| -4% | -$19.6K | 0.52% | 60 |
|
|
2019
Q3 | $479K | Sell |
30,871
-458
| -1% | -$7.54K | 0.5% | 67 |
|
|
2019
Q2 | $538K | Buy |
31,329
+9,760
| +45% | +$157K | 0.6% | 52 |
|
|
2019
Q1 | $347K | Buy |
21,569
+1,256
| +6% | +$20.4K | 0.4% | 75 |
|
|
2018
Q4 | $297K | Buy |
+20,313
| New | +$324K | 0.4% | 70 |
|
|
2015
Q1 | – | Sell |
-16,302
| Closed | -$157K | – | 95 |
|
|
2014
Q4 | $157K | Buy |
+16,302
| New | +$145K | 0.15% | 76 |
|
Other funds holding HALO
VCM
VPM
Verity Asset Management's HALO Position: Q1 2026 in Review
Verity Asset Management increased its Halozyme (HALO) stake by 0.05% in Q1 2026, buying an estimated $1.69K and bringing the position to 53,142 shares worth $3.43M. The position accounts for 1.44% of the portfolio, ranked #11.
Verity Asset Management first reported a position in HALO in Q4 2014 and has held it in 30 quarters since. The position peaked at $3.57M in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Verity Asset Management held 53,142 shares of Halozyme worth $3.43M as of Q1 2026.
- Verity Asset Management bought 24 Halozyme shares in Q1 2026, an estimated $1.69K.
- Halozyme made up 1.44% of Verity Asset Management's portfolio in Q1 2026, its #11 holding.
- Verity Asset Management first reported a position in Halozyme in Q4 2014 and has held it in 30 quarters since.
- Verity Asset Management's Halozyme position peaked at $3.57M in Q4 2025.
- 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Verity Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.